IRBESARTAN
NDC 59746-447, IRBESARTAN, tablet, from Jubilant Cadista Pharmaceuticals Inc..
- Product NDC
- 59746-447
- Status
- Listed
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203534
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59746-447 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IRBESARTAN75 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59746-447-05 | 59746044705 | 500 TABLET in 1 BOTTLE (59746-447-05) |
| 59746-447-30 | 59746044730 | 30 TABLET in 1 BOTTLE (59746-447-30) |
| 59746-447-90 | 59746044790 | 90 TABLET in 1 BOTTLE (59746-447-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/068224c4-a34d-32d7-bb2a-7eed44ccf7d3
Use it
Look up 59746-447 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59746-447 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59746-447. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.